{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260505926208/en/Viridian-Therapeutics-Announces-Positive-Topline-Results-from-Elegrobart-Phase-3-REVEAL%E2%80%912-Clinical-Trial-in-Chronic-Thyroid-Eye-Disease", "message": "News view counter 702868 successfully enlarged"}